[
  {
    "ts": null,
    "headline": "NeoGenomics, Progyny, Repligen, Revvity, and Waters Corporation Shares Are Soaring, What You Need To Know",
    "summary": "A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer Price Index (CPI) report, investors are increasingly betting on a rate reduction next month, a sentiment amplified by U.S. Treasury Secretary Scott Bessent's call for a significant cut. This has fueled a 'risk-on' environment across Wall Street. Lower interest rates are typically beneficial for growth",
    "url": "https://finnhub.io/api/news?id=d3749e1acfc6e1ca9a311738957e5d298a7038b14236e74c88631a7c02bb8675",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755121865,
      "headline": "NeoGenomics, Progyny, Repligen, Revvity, and Waters Corporation Shares Are Soaring, What You Need To Know",
      "id": 136345175,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WAT",
      "source": "Yahoo",
      "summary": "A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer Price Index (CPI) report, investors are increasingly betting on a rate reduction next month, a sentiment amplified by U.S. Treasury Secretary Scott Bessent's call for a significant cut. This has fueled a 'risk-on' environment across Wall Street. Lower interest rates are typically beneficial for growth",
      "url": "https://finnhub.io/api/news?id=d3749e1acfc6e1ca9a311738957e5d298a7038b14236e74c88631a7c02bb8675"
    }
  },
  {
    "ts": null,
    "headline": "5 Insightful Analyst Questions From Waters Corporation’s Q2 Earnings Call",
    "summary": "Waters Corporation reported results for Q2 that exceeded investor expectations, with both sales and adjusted earnings per share meeting or surpassing Wall Street projections. Management attributed growth to robust demand for liquid chromatography and mass spectrometry instruments, particularly in pharmaceutical replacement cycles and contract development manufacturing organizations (CDMOs). CEO Udit Batra pointed to recurring revenue growth, especially in chemistry and service segments, as well",
    "url": "https://finnhub.io/api/news?id=5db1b5ccb07e384c7a3345e82ed1ed6070bbfcf8e6b45c64f7e3c5b99653f73f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755058702,
      "headline": "5 Insightful Analyst Questions From Waters Corporation’s Q2 Earnings Call",
      "id": 136328838,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WAT",
      "source": "Yahoo",
      "summary": "Waters Corporation reported results for Q2 that exceeded investor expectations, with both sales and adjusted earnings per share meeting or surpassing Wall Street projections. Management attributed growth to robust demand for liquid chromatography and mass spectrometry instruments, particularly in pharmaceutical replacement cycles and contract development manufacturing organizations (CDMOs). CEO Udit Batra pointed to recurring revenue growth, especially in chemistry and service segments, as well",
      "url": "https://finnhub.io/api/news?id=5db1b5ccb07e384c7a3345e82ed1ed6070bbfcf8e6b45c64f7e3c5b99653f73f"
    }
  },
  {
    "ts": null,
    "headline": "WAT Q2 CY2025 Deep Dive: Results Ahead of Expectations as Product Innovation and Integration Opportunities Shape Outlook",
    "summary": "Scientific instruments company Waters Corporation (NYSE:WAT) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 8.9% year on year to $771.3 million. Guidance for next quarter’s revenue was better than expected at $781 million at the midpoint, 0.7% above analysts’ estimates. Its non-GAAP profit of $2.95 per share was in line with analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=062076b91b962de727d8e17c560c9dfa431e034269e4939ea7fa4c4142ff605a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755057962,
      "headline": "WAT Q2 CY2025 Deep Dive: Results Ahead of Expectations as Product Innovation and Integration Opportunities Shape Outlook",
      "id": 136328839,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WAT",
      "source": "Yahoo",
      "summary": "Scientific instruments company Waters Corporation (NYSE:WAT) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 8.9% year on year to $771.3 million. Guidance for next quarter’s revenue was better than expected at $781 million at the midpoint, 0.7% above analysts’ estimates. Its non-GAAP profit of $2.95 per share was in line with analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=062076b91b962de727d8e17c560c9dfa431e034269e4939ea7fa4c4142ff605a"
    }
  }
]